Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML
Clinical trial NCT04365179 · UNKNOWN
Trial details
- NCT number
- NCT04365179
- Sponsor
- Immune System Key Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2025-06-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.